Exelixis Inc (EXEL)

Exchange
NASDAQ
Symbol
EXEL
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    32.80
  • High
    33.33
  • Low
    32.44
  • Close
    32.88
  • Volume
    1,981,090

Financial ratios

Dec 31, 2023